One of the most important goals of Xenico Pharma is to provide patients with modern pharmaceutical preparations of the highest quality.

High quality defines the effectiveness of the product, therefore, when developing the concept of a new preparation, extensive research and trials are carried out to determine the optimal technology, composition and properties of the product as well as production parameters.

For the production of Xenico Pharma preparations, we use high-quality raw materials that are often recommended by EFSA – the European Food Safety Authority, as well as pioneering and innovative solutions such as the plant-based cellulose capsule – V-Caps®.

Out of concern for the health and safety of our customers, we ensure that the delivered products are manufactured based on the highest standards of Good Manufacturing Practice. Good Manufacturing Practice. GMP is a combination of effective production procedures and effective production control and supervision, which guarantees that production takes place in conditions enabling the production of products that meet previously established quality requirements.

In addition, it should be emphasised that all our products are manufactured in accordance with current nutritional trends and scientific developments in human nutrition and manufacturing technology. When introducing new products, we systematically use scientific research and cooperate with authorities in the field of science, nutrition and supplementation.

Supporting health and ensuring a better quality of life is the mission of Xenico Pharma. This is possible thanks to continuous development and active cooperation with a group of companies from the Nutribiomed science cluster located in the Wrocław Technology Park, as well as continuous investment in technological facilities. Xenico Pharma puts emphasis on constantly increasing scientific and research potential enabling the production of innovative and effective pharmaceutical preparations.

Through its membership of the National Council for Supplements and Nutrients, Xenico also has access to the latest information on planned legislative changes at European and national level and the opportunity to influence these changes. Through KRSIO, with the help of the Association's experts, the company has the opportunity to undertake joint legislative initiatives and participate in the creation of law.